# Helicobacter Pylori and Body Iron in Adults

> **NCT03146325** · PHASE4 · WITHDRAWN · sponsor: **The University of Texas Health Science Center, Houston**

## Conditions studied

- Helicobacter Pylori Infection

## Interventions

- **DRUG:** BISMUTH TETRACYCLINE METRONIDAZOLE OMEPRAZOLE
- **DRUG:** MATCHING PLACEBO

## Key facts

- **NCT ID:** NCT03146325
- **Lead sponsor:** The University of Texas Health Science Center, Houston
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** WITHDRAWN
- **Start date:** 2012-11
- **Primary completion:** 2016-06
- **Final completion:** 2016-08
- **Target enrollment:** 0 (ACTUAL)
- **Why stopped:** Study was not funded and PI has left the institution
- **Last updated:** 2017-05-09

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03146325

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03146325, "Helicobacter Pylori and Body Iron in Adults". Retrieved via AI Analytics 2026-05-26 from https://api.ai-analytics.org/clinical/NCT03146325. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*